cipla: Why Hamied family’s exit would mark the end of an era for Cipla and millions of patients

YK Hamied, non-executive chairman, Cipla


Cipla may be privately owned, but effectively it has been a ‘national asset’ — with each brick representing Indian ingenuity, enterprise, and strength of character. While shareholders will most likely have no reason to complain, the end losers of Cipla’s founding family’s potential exit will be millions of underprivileged patients in India and the developing world.

In July 1939, when Mahatma Gandhi visited four-year-old Cipla’s Mumbai headquarters, he reportedly extracted a commitment from its founder, Khwaja Abdul Hamied. It was that the pharmaceutical company would support the supply of medicines needed in the ongoing World War II. But more importantly, Gandhi made Hamied promise that no Indian would ever be denied access to essential medicines. Those were the days when almost all medicines were

  • SAVE

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

Leave a Reply

Your email address will not be published. Required fields are marked *